FI61685C - Vid mikrobiologisk framstaellning av antibiotika anvaendbar 1d(1,3,5/2)-1,5-diamino-2,3-cyklohexandiol - Google Patents
Vid mikrobiologisk framstaellning av antibiotika anvaendbar 1d(1,3,5/2)-1,5-diamino-2,3-cyklohexandiol Download PDFInfo
- Publication number
- FI61685C FI61685C FI750405A FI750405A FI61685C FI 61685 C FI61685 C FI 61685C FI 750405 A FI750405 A FI 750405A FI 750405 A FI750405 A FI 750405A FI 61685 C FI61685 C FI 61685C
- Authority
- FI
- Finland
- Prior art keywords
- formula
- diamino
- cyclohexanediol
- aminocyclitol
- tosyl
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 8
- 229940088710 antibiotic agent Drugs 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 4
- 239000007868 Raney catalyst Substances 0.000 claims description 3
- 229910000564 Raney nickel Inorganic materials 0.000 claims description 3
- 230000002906 microbiologic effect Effects 0.000 claims description 3
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 claims description 2
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 claims description 2
- 229910003446 platinum oxide Inorganic materials 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 8
- 239000013078 crystal Substances 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 6
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- -1 alkali metal azide Chemical class 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- ANLMVXSIPASBFL-MBWODLHSSA-N 2-epi-Streptamine Chemical compound N[C@H]1[C@@H](O)[C@@H](N)[C@H](O)[C@@H](O)[C@@H]1O ANLMVXSIPASBFL-MBWODLHSSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- ANLMVXSIPASBFL-UHFFFAOYSA-N Streptamin D Natural products NC1C(O)C(N)C(O)C(O)C1O ANLMVXSIPASBFL-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- ANLMVXSIPASBFL-FAEUDGQSSA-N streptamine Chemical compound N[C@H]1[C@H](O)[C@@H](N)[C@H](O)[C@@H](O)[C@@H]1O ANLMVXSIPASBFL-FAEUDGQSSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910000838 Al alloy Inorganic materials 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000187438 Streptomyces fradiae Species 0.000 description 1
- 241000187419 Streptomyces rimosus Species 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000003999 cyclitols Chemical class 0.000 description 1
- PDXRQENMIVHKPI-UHFFFAOYSA-N cyclohexane-1,1-diol Chemical class OC1(O)CCCCC1 PDXRQENMIVHKPI-UHFFFAOYSA-N 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI802250A FI62284C (fi) | 1974-02-15 | 1980-07-15 | Som mellanprodukt foer 1d-(1,3,5/2)-1,5-diamino-2,3-cyklohexadiol anvaendbar 1d-(1,3,5/2)-1,5-diazido-2,3-cyklohexandiol och foerfarande foer dess framstaellning |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7405110 | 1974-02-15 | ||
| FR7405110A FR2270235B1 (instruction) | 1974-02-15 | 1974-02-15 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI750405A7 FI750405A7 (instruction) | 1975-08-16 |
| FI61685B FI61685B (fi) | 1982-05-31 |
| FI61685C true FI61685C (fi) | 1982-09-10 |
Family
ID=9134935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI750405A FI61685C (fi) | 1974-02-15 | 1975-02-14 | Vid mikrobiologisk framstaellning av antibiotika anvaendbar 1d(1,3,5/2)-1,5-diamino-2,3-cyklohexandiol |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US3952027A (instruction) |
| JP (1) | JPS5929062B2 (instruction) |
| AR (1) | AR204193A1 (instruction) |
| AT (1) | AT334873B (instruction) |
| BE (1) | BE825456A (instruction) |
| CA (1) | CA1042919A (instruction) |
| CH (2) | CH599928A5 (instruction) |
| DE (1) | DE2506305C2 (instruction) |
| DK (1) | DK4475A (instruction) |
| ES (1) | ES434746A1 (instruction) |
| FI (1) | FI61685C (instruction) |
| FR (1) | FR2270235B1 (instruction) |
| GB (2) | GB1445674A (instruction) |
| HU (1) | HU168810B (instruction) |
| IE (1) | IE40955B1 (instruction) |
| IT (1) | IT1044269B (instruction) |
| NL (1) | NL179050C (instruction) |
| NO (2) | NO139436C (instruction) |
| OA (1) | OA04961A (instruction) |
| SE (2) | SE420918B (instruction) |
| SU (1) | SU545253A3 (instruction) |
| YU (1) | YU36684B (instruction) |
| ZA (1) | ZA75548B (instruction) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5480992A (en) * | 1993-09-16 | 1996-01-02 | Eli Lilly And Company | Anomeric fluororibosyl amines |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3496196A (en) * | 1965-10-02 | 1970-02-17 | Tanabe Pharm Co Ltd | 4,6-diazido-4,6-dideoxy-myo-inositol tetraacylates |
-
1974
- 1974-02-15 FR FR7405110A patent/FR2270235B1/fr not_active Expired
-
1975
- 1975-01-01 AR AR257585A patent/AR204193A1/es active
- 1975-01-09 DK DK4475*#A patent/DK4475A/da not_active Application Discontinuation
- 1975-01-24 IE IE147/75A patent/IE40955B1/xx unknown
- 1975-01-27 ZA ZA00750548A patent/ZA75548B/xx unknown
- 1975-01-27 NL NLAANVRAGE7500905,A patent/NL179050C/xx not_active IP Right Cessation
- 1975-01-31 GB GB441775A patent/GB1445674A/en not_active Expired
- 1975-01-31 US US05/545,799 patent/US3952027A/en not_active Expired - Lifetime
- 1975-01-31 GB GB364676A patent/GB1445675A/en not_active Expired
- 1975-02-05 IT IT19946/75A patent/IT1044269B/it active
- 1975-02-07 YU YU0276/75A patent/YU36684B/xx unknown
- 1975-02-12 BE BE153295A patent/BE825456A/xx unknown
- 1975-02-13 CH CH173975A patent/CH599928A5/xx not_active IP Right Cessation
- 1975-02-13 HU HULA856A patent/HU168810B/hu unknown
- 1975-02-13 AT AT106675A patent/AT334873B/de not_active IP Right Cessation
- 1975-02-13 SE SE7501612A patent/SE420918B/xx unknown
- 1975-02-13 CH CH1051677A patent/CH601183A5/xx not_active IP Right Cessation
- 1975-02-14 ES ES434746A patent/ES434746A1/es not_active Expired
- 1975-02-14 FI FI750405A patent/FI61685C/fi not_active IP Right Cessation
- 1975-02-14 JP JP50019375A patent/JPS5929062B2/ja not_active Expired
- 1975-02-14 CA CA220,156A patent/CA1042919A/en not_active Expired
- 1975-02-14 DE DE2506305A patent/DE2506305C2/de not_active Expired
- 1975-02-14 NO NO750499A patent/NO139436C/no unknown
- 1975-02-14 SU SU2105544A patent/SU545253A3/ru active
- 1975-02-15 OA OA55411A patent/OA04961A/xx unknown
-
1978
- 1978-02-07 SE SE7801405A patent/SE420916B/sv unknown
- 1978-08-29 NO NO782941A patent/NO141688C/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4757139A (en) | 5-fluoro-2'-deoxyuridine derivative, processes for preparing same and antitumor composition containing the same | |
| EP1904493B1 (en) | Tetrahydroprotoberberine compounds, the synthetic method and the use thereof | |
| Chia et al. | Synthesis and anti-inflammatory structure–activity relationships of thiazine–quinoline–quinones: Inhibitors of the neutrophil respiratory burst in a model of acute gouty arthritis | |
| McCormick et al. | The 6-Deoxytetracyclines. 1 Further Studies on the Relationship between Structure and Antibacterial Activity in the Tetracycline Series | |
| SU1586521A3 (ru) | Способ получени производных гликопептидов | |
| US3665018A (en) | Naphthacene derivatives | |
| EP0815110B1 (de) | Halogenierte -carbolin-derivate, verfahren zu ihrer herstellung und verwendung dieser substanzen zur hemmung der atmungskette | |
| DE69104948T2 (de) | Spiro[4,5]decanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. | |
| FI61685C (fi) | Vid mikrobiologisk framstaellning av antibiotika anvaendbar 1d(1,3,5/2)-1,5-diamino-2,3-cyklohexandiol | |
| JPH08269065A (ja) | ピリピロペン誘導体 | |
| FR2623808A1 (fr) | Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| EP0072531A1 (de) | Neue Cyclophosphamid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE69033342T2 (de) | Etoposidanaloge | |
| OMURA et al. | Chemistry of leucomycins. VIII. Absolute configuration of leucomycin and isoleucomycin | |
| DE3625738A1 (de) | 2-acyloxypropylamin-derivate, verfahren zu deren herstellung und deren verwendung | |
| Wong et al. | Stereochemistry of (-)-deoxynupharidine. Synthesis of (R)(-)-. alpha.-methyladipic acid | |
| Maggi et al. | Rifamycins. LIX. Acetyl migration in rifampicin | |
| US4782054A (en) | Tetrahydroquinoline morpholine compounds, compositions and use | |
| FI62284C (fi) | Som mellanprodukt foer 1d-(1,3,5/2)-1,5-diamino-2,3-cyklohexadiol anvaendbar 1d-(1,3,5/2)-1,5-diazido-2,3-cyklohexandiol och foerfarande foer dess framstaellning | |
| Lown et al. | 10-Acetyl-10-hydroxyxantho [2, 3-f] tetralin 8-glycosides as angular chromophore analogs of anthracyclines: synthesis, redox properties, microsomal oxygen consumption, and antileukemic evaluation | |
| PT87631B (pt) | Processo para a preparacao de derivados de mono-hidroxi-acilo e de poli-hidroxi-acilo de labdano polioxigenados e de composicoes farmaceuticas que os contem | |
| US3275638A (en) | Chjcoo- | |
| US4900737A (en) | Isoquinoline derivatives | |
| HU182322B (en) | Process for preparing 1-nitro-9-/hydroxy-alkylamino/-acridines and salts thereof | |
| SU1274626A3 (ru) | Способ получени @ - метил-11 -аза - 10 -деоксо- 10-дигидроэритромицина @ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: SANOFI |